Loading...

Media is loading
 

Date of Award

Spring 2023

Degree Name

Master of Medical Science (Physician Assistant)

Department

Physician Assistant; College of Health Sciences

First Advisor

Dr. Basile

Abstract

Parkinson's disease (PD) is a neurocognitive disease affecting over 6.2 million individuals, with the projected number of individuals affected being 12 million by 2040. Patients with PD have the classical presentation of bradykinesia, resting tremors, muscle rigidity and postural/gait abnormalities. The current pharmacological treatments for PD are levodopa/carbidopa, COMT inhibitors, Monoamine oxidase-B (MAO-B) inhibitors, dopamine (DA) receptor agonists, anticholinergics, and amantadine with levodopa/carbidopa being the gold standard. Exercise serves as a non-pharmacological therapeutic option. Even though the research is limited, boxing continues to grow in popularity across the US as a therapeutic option for PD. With PD incidence on the rise, it is crucial that practitioners are prepared to ensure the best possible outcome for their patients.

Download

Share

COinS
 

Management of Parkinson's Disease

Parkinson's disease (PD) is a neurocognitive disease affecting over 6.2 million individuals, with the projected number of individuals affected being 12 million by 2040. Patients with PD have the classical presentation of bradykinesia, resting tremors, muscle rigidity and postural/gait abnormalities. The current pharmacological treatments for PD are levodopa/carbidopa, COMT inhibitors, Monoamine oxidase-B (MAO-B) inhibitors, dopamine (DA) receptor agonists, anticholinergics, and amantadine with levodopa/carbidopa being the gold standard. Exercise serves as a non-pharmacological therapeutic option. Even though the research is limited, boxing continues to grow in popularity across the US as a therapeutic option for PD. With PD incidence on the rise, it is crucial that practitioners are prepared to ensure the best possible outcome for their patients.